Latest period
$6.56B
YoY change
+4.8%
5Y CAGR
-2.4%
Peak year (2020)
$7.83B
Latest annual
$6.95B
Total Debt history chart for Biogen (BIIB) from 1985 to 2025
Latest: $6.95B
Total Debt growth chart for Biogen (BIIB) from 1985 to 2025
Latest: +4.8%
Total Debt history table for Biogen (BIIB) from 1985 to 2025
| 2025 | $6.95B | +4.8% | +$317.70M | ||
| 2024 | $6.63B | -9.6% | −$707.90M | ||
| 2023 | $7.34B | +10.9% | +$724.20M | ||
| 2022 | $6.61B | -13.0% | −$989.50M | ||
| 2021 | $7.60B | -2.9% | −$224.70M | ||
| 2020 | $7.83B | +22.9% | +$1.46B | ||
| 2019 | $6.37B | +7.3% | +$431.00M | ||
| 2018 | $5.94B | -0.0% | −$1.70M | ||
| 2017 | $5.94B | -8.9% | −$579.20M | ||
| 2016 | $6.52B | -0.1% | −$8.90M | ||
| 2015 | $6.53B | +1015.2% | +$5.94B | ||
| 2014 | $585.20M | -1.8% | −$10.73M | ||
| 2013 | $595.93M | -47.8% | −$544.85M | ||
| 2012 | $1.14B | +7.2% | +$76.67M | ||
| 2011 | $1.06B | -11.6% | −$139.43M | ||
| 2010 | $1.20B | +9.4% | +$103.56M | ||
| 2009 | $1.10B | -1.2% | −$13.13M | ||
| 2008 | $1.11B | -28.8% | −$449.88M | ||
| 2007 | $1.56B | +1516.4% | +$1.47B | ||
| 2006 | $96.69M | +122.6% | +$53.25M | ||
| 2005 | $43.44M | -94.9% | −$806.87M | ||
| 2004 | $850.31M | -4.2% | −$36.96M | ||
| 2003 | $887.27M | +1997.7% | +$844.97M | ||
| 2002 | $42.30M | -48.5% | −$39.86M | ||
| 2001 | $82.16M | -24.8% | −$27.16M | ||
| 2000 | $109.32M | -3.3% | −$3.74M | ||
| 1999 | $113.06M | +40.8% | +$32.73M | ||
| 1998 | $80.33M | -12.3% | −$11.22M | ||
| 1997 | $91.55M | +38.1% | +$25.28M | ||
| 1996 | $66.27M | +92.1% | +$31.78M | ||
| 1995 | $34.49M | — | +$34.49M | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | $0.00 | ||
| 1989 | $0.00 | -100.0% | −$4.80M | ||
| 1988 | $4.80M | -7.7% | −$400.00K | ||
| 1987 | $5.20M | +18.2% | +$800.00K | ||
| 1986 | $4.40M | +22.2% | +$800.00K | ||
| 1985 | $3.60M | — | — |
- 2025$6.95B+4.8%
- 2024$6.63B-9.6%
- 2023$7.34B+10.9%
- 2022$6.61B-13.0%
- 2021$7.60B-2.9%
- 2020$7.83B+22.9%
- 2019$6.37B+7.3%
- 2018$5.94B-0.0%
- 2017$5.94B-8.9%
- 2016$6.52B-0.1%
- 2015$6.53B+1015.2%
- 2014$585.20M-1.8%
- 2013$595.93M-47.8%
- 2012$1.14B+7.2%
- 2011$1.06B-11.6%
- 2010$1.20B+9.4%
- 2009$1.10B-1.2%
- 2008$1.11B-28.8%
- 2007$1.56B+1516.4%
- 2006$96.69M+122.6%
- 2005$43.44M-94.9%
- 2004$850.31M-4.2%
- 2003$887.27M+1997.7%
- 2002$42.30M-48.5%
- 2001$82.16M-24.8%
- 2000$109.32M-3.3%
- 1999$113.06M+40.8%
- 1998$80.33M-12.3%
- 1997$91.55M+38.1%
- 1996$66.27M+92.1%
- 1995$34.49M—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
- 1989$0.00-100.0%
- 1988$4.80M-7.7%
- 1987$5.20M+18.2%
- 1986$4.40M+22.2%
- 1985$3.60M—
Total Debt values are taken from Biogen's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported total debt is $6.56B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Biogen (BIIB) most recent annual total debt stands at $6.95B (2025) – edged up 4.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Biogen total debt compounded at -2.4% per year, with a net decline across the window.
The highest annual total debt of $7.83B was reported in 2020. The lowest in the available history was $0.00 in 1989.
Biogen Total Debt by Year
Biogen Total Debt 2025: $6.95B
In 2025, Biogen reported total debt of $6.95B, edged up 4.8% from 2024.
Biogen Total Debt 2024: $6.63B
Biogen total debt in 2024 was $6.63B, declined 9.6% below 2023.
Biogen Total Debt 2023: $7.34B
2023's total debt for Biogen came in at $7.34B, grew 10.9% from 2022.
Biogen Total Debt 2022: $6.61B
Biogen posted total debt of $6.61B in 2022, declined 13.0% below 2021.
Biogen Total Debt 2021: $7.60B
Biogen total debt in 2021 was $7.60B.
See more financial history for Biogen (BIIB).
Sector peers by Total Debt
Healthcare peers of Biogen (BIIB), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation